BSEM
Income statement / Annual
Last year (2025), BioStem Technologies Inc's total revenue was $47.48 M,
a decrease of 84.27% from the previous year.
In 2025, BioStem Technologies Inc's net income was -$6.58 M.
See BioStem Technologies Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$47.48 M |
$301.83 M |
$16.69 M |
$6.88 M |
$4.34 M |
$2.52 M |
$2.63 M |
$1.02 M |
$328.53 K |
$592.30 K |
| Cost of Revenue |
$3.26 M
|
$13.75 M
|
$1.26 M
|
$881.75 K
|
$1.47 M
|
$1.27 M
|
$1.32 M
|
$602.01 K
|
$149.67 K
|
$359.51 K
|
| Gross Profit |
$44.22 M
|
$288.08 M
|
$15.42 M
|
$5.99 M
|
$2.87 M
|
$1.25 M
|
$1.31 M
|
$415.18 K
|
$178.86 K
|
$232.79 K
|
| Gross Profit Ratio |
0.93
|
0.95
|
0.92
|
0.87
|
0.66
|
0.5
|
0.5
|
0.41
|
0.54
|
0.39
|
| Research and Development Expenses |
$7.09 M
|
$1.91 M
|
$342.00 K
|
$224.78 K
|
$119.65 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$18.69 M
|
$10.65 M
|
$9.25 M
|
$4.19 M
|
$3.09 M
|
$7.04 M
|
$8.18 M
|
$5.01 M
|
$3.62 M
|
| Selling & Marketing Expenses |
$0.00
|
$236.06 M
|
$11.99 M
|
$954.06 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$37.82 M
|
$254.75 M
|
$22.63 M
|
$10.21 M
|
$4.19 M
|
$3.09 M
|
$7.04 M
|
$8.18 M
|
$5.01 M
|
$3.62 M
|
| Other Expenses |
$0.00
|
$221.30 K
|
$229.01 K
|
$243.42 K
|
$164.26 K
|
$1.00
|
$0.00
|
$0.00
|
$327.00
|
-$9.27 K
|
| Operating Expenses |
$44.91 M
|
$256.88 M
|
$23.20 M
|
$10.67 M
|
$4.47 M
|
$3.09 M
|
$7.04 M
|
$8.18 M
|
$5.01 M
|
$3.62 M
|
| Cost And Expenses |
$48.17 M
|
$270.63 M
|
$24.46 M
|
$11.56 M
|
$5.95 M
|
$4.36 M
|
$8.36 M
|
$8.78 M
|
$5.16 M
|
$3.98 M
|
| Interest Income |
$413.85 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$3.93 K
|
$9.25 K
|
$4.27 K
|
$327.00
|
$0.00
|
| Interest Expense |
$0.00
|
$587.22 K
|
$700.33 K
|
$468.15 K
|
$525.88 K
|
$530.90 K
|
$633.02 K
|
$255.95 K
|
$33.77 K
|
$50.21 K
|
| Depreciation & Amortization |
$381.02 K
|
$293.22 K
|
$229.02 K
|
$222.47 K
|
$283.79 K
|
$243.47 K
|
$334.12 K
|
$203.09 K
|
$186.05 K
|
$162.71 K
|
| EBITDA |
-$308.13 K |
$31.49 M |
-$7.55 M |
-$6.54 M |
-$602.11 K |
-$1.59 M |
-$5.38 M |
-$7.28 M |
-$4.59 M |
-$2.99 M |
| EBITDA Ratio |
-0.01
|
0.1
|
-0.45
|
-0.95
|
-0.14
|
-0.63
|
-2.05
|
-7.16
|
-13.98
|
-5.05
|
| Operating Income Ratio |
-0.01
|
0.1
|
-0.47
|
-0.68
|
-0.37
|
-0.73
|
-2.18
|
-7.64
|
-14.7
|
-5.71
|
| Total Other Income/Expenses Net |
$299.50 K
|
-$587.22 K
|
-$704.02 K
|
-$2.55 M
|
$193.93 K
|
-$526.97 K
|
-$619.20 K
|
$29.45 K
|
$16.19 K
|
-$184.10 K
|
| Income Before Tax |
-$389.65 K
|
$30.61 M
|
-$8.48 M
|
-$7.23 M
|
-$1.41 M
|
-$2.37 M
|
-$6.35 M
|
-$7.74 M
|
-$4.86 M
|
-$3.57 M
|
| Income Before Tax Ratio |
-0.01
|
0.1
|
-0.51
|
-1.05
|
-0.33
|
-0.94
|
-2.41
|
-7.61
|
-14.8
|
-6.02
|
| Income Tax Expense |
$6.19 M
|
-$1.27 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$667.99 K
|
$0.00
|
$13.33 K
|
$25.98 K
|
| Net Income |
-$6.58 M
|
$31.88 M
|
-$8.48 M
|
-$7.19 M
|
-$1.45 M
|
-$2.39 M
|
-$6.38 M
|
-$7.59 M
|
-$4.84 M
|
-$3.56 M
|
| Net Income Ratio |
-0.14
|
0.11
|
-0.51
|
-1.05
|
-0.33
|
-0.95
|
-2.43
|
-7.47
|
-14.74
|
-6.02
|
| EPS |
-0.39 |
1.95 |
-0.62 |
-0.63 |
-0.15 |
-0.26 |
-0.69 |
-0.94 |
-0.95 |
-1.07 |
| EPS Diluted |
-0.39 |
1.47 |
-0.62 |
-0.63 |
-0.15 |
-0.26 |
-0.69 |
-0.94 |
-0.95 |
-1.07 |
| Weighted Average Shares Out |
$16.73 M
|
$16.37 M
|
$13.71 M
|
$11.40 M
|
$9.32 M
|
$9.18 M
|
$9.25 M
|
$8.11 M
|
$5.07 M
|
$3.33 M
|
| Weighted Average Shares Out Diluted |
$16.73 M
|
$21.70 M
|
$13.71 M
|
$11.40 M
|
$9.32 M
|
$9.18 M
|
$9.25 M
|
$8.11 M
|
$5.07 M
|
$3.33 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
